{"id":"https://openalex.org/W4307340608","doi":"https://doi.org/10.1111/hae.14684","title":"Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab","display_name":"Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab","publication_year":2022,"publication_date":"2022-10-26","ids":{"openalex":"https://openalex.org/W4307340608","doi":"https://doi.org/10.1111/hae.14684","pmid":"https://pubmed.ncbi.nlm.nih.gov/36287631"},"language":"en","primary_location":{"id":"doi:10.1111/hae.14684","doi":"https://doi.org/10.1111/hae.14684","is_oa":false,"landing_page_url":"https://doi.org/10.1111/hae.14684","pdf_url":null,"source":{"id":"https://openalex.org/S37667796","display_name":"Haemophilia","issn_l":"1351-8216","issn":["1351-8216","1355-0691","1365-2516"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048561431","display_name":"Hande K\u0131z\u0131locak","orcid":"https://orcid.org/0000-0003-0323-2571","observed_orcids":["https://orcid.org/0000-0003-0323-2571"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hande Kizilocak","raw_affiliation_strings":["Children's Hospital Los Angeles, Hemostasis and Thrombosis Center Los Angeles California USA"],"raw_orcid":"https://orcid.org/0000-0003-0323-2571","affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Hemostasis and Thrombosis Center Los Angeles California USA","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089807659","display_name":"Elizabeth Marquez\u2010Casas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Marquez\u2010Casas","raw_affiliation_strings":["Children's Hospital Los Angeles, Hemostasis and Thrombosis Center Los Angeles California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Hemostasis and Thrombosis Center Los Angeles California USA","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060869564","display_name":"Jemily Malvar","orcid":"https://orcid.org/0000-0002-5481-6780","observed_orcids":["https://orcid.org/0000-0002-5481-6780"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jemily Malvar","raw_affiliation_strings":["Children's Hospital Los Angeles, Cancer and Blood Disease Institute Los Angeles California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Cancer and Blood Disease Institute Los Angeles California USA","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004338432","display_name":"Guy A. Young","orcid":"https://orcid.org/0000-0001-6013-1254","observed_orcids":["https://orcid.org/0000-0001-6013-1254"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Guy Young","raw_affiliation_strings":["Children's Hospital Los Angeles, Hemostasis and Thrombosis Center Los Angeles California USA","University of Southern California, Keck School of Medicine Los Angeles California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Hemostasis and Thrombosis Center Los Angeles California USA","institution_ids":["https://openalex.org/I1336910626"]},{"raw_affiliation_string":"University of Southern California, Keck School of Medicine Los Angeles California USA","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004338432"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":2.5093,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.9110009,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"29","issue":"1","first_page":"100","last_page":"105"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/activated-prothrombin-complex-concentrate","display_name":"activated prothrombin complex concentrate","score":0.8949999809265137},{"id":"https://openalex.org/keywords/emicizumab","display_name":"emicizumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9710000157356262},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.625},{"id":"https://openalex.org/keywords/breakthrough-bleeding","display_name":"breakthrough bleeding","score":0.9660000205039978},{"id":"https://openalex.org/keywords/thrombotic-complications","display_name":"thrombotic complications","score":0.8389999866485596},{"id":"https://openalex.org/keywords/thrombin-generation","display_name":"thrombin generation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6340000033378601},{"id":"https://openalex.org/keywords/recombinant-factor-viia","display_name":"recombinant factor VIIa","score":0.8460000157356262},{"id":"https://openalex.org/keywords/feiba","display_name":"FEIBA","score":0.6480000019073486},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9479466080665588},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.7045882940292358},{"id":"https://openalex.org/C2778385053","wikidata":"https://www.wikidata.org/wiki/Q134003","display_name":"Haemophilia","level":2,"score":0.6650667190551758},{"id":"https://openalex.org/C2777902738","wikidata":"https://www.wikidata.org/wiki/Q1268495","display_name":"Breakthrough bleeding","level":5,"score":0.5996941924095154},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5305308103561401},{"id":"https://openalex.org/C2777232031","wikidata":"https://www.wikidata.org/wiki/Q2092064","display_name":"Haemophilia A","level":3,"score":0.4764269292354584},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.38475412130355835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34275177121162415},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.09782013297080994},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2986817661","wikidata":"https://www.wikidata.org/wiki/Q185698","display_name":"Research methodology","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2779076696","wikidata":"https://www.wikidata.org/wiki/Q1280670","display_name":"Family planning","level":4,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001779","descriptor_name":"Blood Coagulation Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001779","descriptor_name":"Blood Coagulation Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005164","descriptor_name":"Factor IX","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008796","descriptor_name":"Metrorrhagia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/hae.14684","doi":"https://doi.org/10.1111/hae.14684","is_oa":false,"landing_page_url":"https://doi.org/10.1111/hae.14684","pdf_url":null,"source":{"id":"https://openalex.org/S37667796","display_name":"Haemophilia","issn_l":"1351-8216","issn":["1351-8216","1355-0691","1365-2516"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia","raw_type":"journal-article"},{"id":"pmid:36287631","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36287631","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia : the official journal of the World Federation of Hemophilia","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5473145961","display_name":null,"funder_award_id":"IIR\u2010US\u2010002681","funder_id":"https://openalex.org/F4320310465","funder_display_name":"Takeda Pharmaceutical Company"}],"funders":[{"id":"https://openalex.org/F4320310465","display_name":"Takeda Pharmaceutical Company","ror":"https://ror.org/04hjbmv12"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W2734287351","https://openalex.org/W2805799263","https://openalex.org/W2808215790","https://openalex.org/W2888898681","https://openalex.org/W2936143155","https://openalex.org/W2945243639","https://openalex.org/W2958765768","https://openalex.org/W2965671309","https://openalex.org/W2980900975","https://openalex.org/W3038087455","https://openalex.org/W3107640905"],"related_works":["https://openalex.org/W3107640905","https://openalex.org/W4411372909","https://openalex.org/W2808215790","https://openalex.org/W4391393431","https://openalex.org/W3217691479","https://openalex.org/W7034090953","https://openalex.org/W7152643707","https://openalex.org/W3174289267","https://openalex.org/W3097383180","https://openalex.org/W3084233299"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Emicizumab":[1],"is":[2],"a":[3,162],"humanized":[4],"bispecific":[5],"monoclonal":[6],"antibody":[7],"licensed":[8],"for":[9,136,226],"patients":[10,20,43,64,71,118,132,153,198,204],"with":[11,27,72,76,89,99,158],"severe":[12,73],"haemophilia":[13,74],"A.":[14],"Breakthrough":[15],"bleeding":[16,219],"still":[17],"occurs":[18],"in":[19,94,108,143,172,186,190,246],"on":[21,44,65,80],"emicizumab":[22,45,81,230],"and":[23,127,231],"can":[24],"be":[25,236],"managed":[26],"recombinant":[28],"factor":[29],"VIIa":[30],"(rFVIIa)":[31],"or":[32],"activated":[33],"prothrombin":[34],"complex":[35],"concentrate":[36],"(aPCC).":[37],"Thrombotic":[38],"events":[39],"were":[40,82,87,97,133],"reported":[41],"when":[42],"received":[46],"concomitant":[47,227],"aPCC":[48,62,93,126,160,184,194,242],"at":[49,161,208],"relatively":[50],"high":[51],"doses.":[52],"We":[53],"studied":[54],"the":[55,106,112,120,137,141,147,155,176,196,203,209,215,223],"effect":[56],"of":[57,61,92,111,116,125,130,146,151,175,183,193,202,212,217,229,241],"infusing":[58],"various":[59],"doses":[60,91,211,240],"to":[63,84,167,195],"emicizumab.":[66],"MATERIAL":[67],"AND":[68],"METHODS:":[69],"Nine":[70],"A":[75],"inhibitors":[77],"who":[78],"are":[79],"recruited":[83],"participate.":[85],"Patients":[86],"infused":[88],"varying":[90],"vivo.":[95],"Samples":[96],"tested":[98],"thrombin":[100],"generation":[101],"(TG)":[102],"assay.":[103],"RESULTS:":[104],"In":[105,140,214],"current":[107],"vivo":[109,191],"arm":[110,145],"study":[113,148,177],"four":[114],"out":[115,129,150],"nine":[117,131],"reached":[119,154],"highest":[121,138],"dose,":[122],"75":[123],"U/kg":[124],"six":[128],"actually":[134],"eligible":[135],"dose.":[139],"previous":[142],"vitro":[144,173],"seven":[149],"eight":[152],"normal":[156,206],"plasma":[157],"spiking":[159],"very":[163],"low":[164,239],"concentration":[165],"equivalent":[166],"5":[168],"U/kg.":[169],"CONCLUSION:":[170],"The":[171],"portion":[174],"demonstrated":[178,199],"that":[179,200,238],"clinically":[180],"relevant":[181],"concentrations":[182],"resulted":[185],"excessive":[187],"TG,":[188],"however,":[189,233],"administration":[192],"same":[197],"most":[201],"had":[205],"TG":[207],"approved":[210],"aPCC.":[213],"management":[216],"breakthrough":[218],"clinicians":[220],"should":[221,234],"heed":[222],"boxed":[224],"warning":[225],"use":[228],"aPCC,":[232],"also":[235],"aware":[237],"may":[243],"not":[244],"result":[245],"sufficient":[247],"TG.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-10-31T00:00:00"}